Dr. Lindy Ross Certified in Pediatric Dermatology

Congratulations to UTMB Dermatology Assistant Professor Lindy Ross, MD for achieving board certification in the subspecialty of pediatric dermatology following examination by the American Board of Dermatology this year.

UTMB Interviews for Dermatology Residency Applicants

UTMB Dermatology will interview applicants for dermatology residency positions in January 2026. Invited applicants were from 14 different states or territories and 25 different medical schools (7 in Texas). 29 applicants were current or past rotators in the department, and an additional 11 applicants were non-rotators. 9 applicants had additional research degrees (PhD, MPH, or Master’s) in additional to MD degrees.

UTMB Named as Qualified Treatment Center for ZEVASKYN®, a treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Abeona Therapeutics® has announced that UTMB is New Qualified Treatment Center for ZEVASKYN® in Texas.

ZEVASKYN (prademagene zamikeracel) is a FDA-approved autologous gene therapy that is indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). UTMB Dermatology Assistant Professors Drs. A. Munoz and L. Ross, along with Nurse Manager Jennifer Tribble, MSN, RN were instrumental in getting this new therapy available in Galveston.

 

UTMB 2026-2027 Mohs Fellow Announced

Congratulations to Renat Ahatov, MD, a current PGY4 UTMB dermatology resident for matching into the UTMB MSDO Fellowship starting in July 2026. He will be the 11^th UTMB Mohs fellow. We are all looking forward to working with you!

UTMB MS4 Publishes in Journal of the American Academy of Dermatology

Congratulations to Madelyn Schmidt, UTMB MS4 and President of the UTMB DIG for her recent publication about tranexamic acid and melanoma risk in the highly regarded peer-reviewed journal, Journal of the American Academy of Dermatology. Her UTMB co-authors are UTMB PGY3 dermatology resident, Dr. Marie Vu, UTMB MS3  S. Gandhi, and UTMB Professor Dermatology and Chair, Dr. Michael Wilkerson.  

The citation is: Schmidt M, Vu M, Smiti Gandhi, Wilkerson M. A retrospective cohort study evaluating the impact of tranexamic acid on melanoma risk. J Am Acad Dermatol. 2025 Nov;93(5):1301-1303. doi: 10.1016/j.jaad.2025.07.006. Epub 2025 Jul 8. PMID: 40639475.

Where are they now?

Ever wonder where UTMB dermatology residents practice dermatology when they graduate? Thanks to the efforts of two UTMB MS3s (Danielle Miller and Nikitha Adari), along with administrative support from Rey Lopez and Michelle Karn, two new maps in the Chair’s administrative offices show where our graduates practice. In addition, plans are underway to map where our fellowship trainees go with supspecialty expertise in dermatopathology and Mohs surgery, as well as those with combined training in dermatology and either dermatopathology or Mohs surgery at UTMB.

UTMB Hosting Japanese Dermatologist During December 2025

Please welcome Dr. Mana Myoshi, who will be visiting the UTMB Department of Dermatology for 2 weeks during December 2025 as part of the exchange program with Hokkaido, Japan's Tokushukai Hospital (TKH). It will be a great learning opportunity for everyone!

Dr. Erica Kelly Featured Speaker at Houston Dermatological Society Monthly Meeting

Congratulations to Dr. Erica Kelly (Clinical Professor, UTMB Department of Dermatology, and Director of the UTMB Cosmetic Dermatology Service) who was the featured speaker at the December 2025 Houston Dermatological Society Meeting on the topic “Estrogen Creams: Science or Hype?”